HIV-1 Variants and Antibody Sensitivity
Author Information
Author(s): Haldar Bijayesh, Burda Sherri, Williams Constance, Heyndrickx Leo, Vanham Guido, Gorny Miroslaw K., Nyambi Phillipe
Primary Institution: New York University School of Medicine
Hypothesis
To study how virus evolution affects neutralization sensitivity and to determine changes that occur in and around epitopes.
Conclusion
The study shows that HIV-1 can evolve increased sensitivity to neutralization by specific monoclonal antibodies over time.
Supporting Evidence
- Primary viruses collected from patients at first visit were resistant to neutralization by all anti-HIV-1 mAbs except one.
- Four of the five patients' viruses evolved increased sensitivity to neutralization by anti-V3 mAbs.
- The study demonstrates that HIV-1 can evolve increased neutralization sensitivity to mAbs over time.
Takeaway
The study found that some HIV-1 viruses can become easier to neutralize by antibodies as they change over time.
Methodology
The study tested the ability of 13 anti-HIV-1 monoclonal antibodies to neutralize sequential viruses obtained from five HIV-1 chronically infected drug-naive individuals.
Limitations
The study involved a small sample size of five patients, which may limit the generalizability of the findings.
Participant Demographics
Five HIV-1 chronically infected drug-naive individuals, asymptomatic during the study.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website